Evotec signs €60m contract with US NIH
To manage the NIH Small Molecule Repository for 10 years
Evotec has entered into a €60m (US$75m) multi-year compound management agreement with the US National Institutes of Health (NIH), Department of Health and Human Services, for the operation of a Small Molecule Repository.
The NIH will provide the funding for the 10-year contract.
The NIH Small Molecule Repository (SMR) contract will continue to provide services initiated previously under contract N01MH41001 to acquire, store, maintain, and distribute the current library collection, supporting certain NIH-supported screening Centres conducting high-throughput screening (HTS) for probe and drug discovery.
The contract resource will now be made available to selected outside collaborators.
Dr Mario Polywka, chief operating officer of Evotec, said: ‘This long-term contract will be managed through our San Francisco subsidiary, however, we are also currently developing options to expand our compound management capabilities into the East Coast of the USA and also into Europe.’
